Navigation Links
JDRF funded study links 'hygiene hypothesis' to diabetes prevention
Date:10/6/2008

New York, NY, October 6, 2008 -- A research study funded by JDRF suggests that a common intestinal bacteria may provide some protection from developing type 1 diabetes. The findings provide an important step towards understanding how and why type 1 diabetes develops in people, and may lead to potential cures.

The study, reported this week in Nature Magazine, lends further support to the "hygiene hypothesis," that exposure to an appropriate amount and composition of bacteria may be important to living a healthy life, and that susceptibility to type 1 diabetes and other autoimmune disorders may actually be caused by a lack of exposure to certain parasites and microbes.

In the study, researchers at Yale University and the University of Chicago found that exposure to certain bacteria will trigger an immune system response in mice. That response is believed to be what prevents autoimmune disorders -- conditions where the immune system attacks healthy cells in the body. In people with type 1 diabetes, the immune system attacks the beta cells in the pancreas, stopping a person's ability to detect glucose and produce insulin. For the purposes of the study, the bacteria used were harmless microbes typically found in the human intestine. The scientists suggest that safe, measured exposure to certain bacteria may lower the risk of immune disorders.

"This study outcome gives us a new avenue to explore", said JDRF Executive Vice President of Research, Richard A. Insel, MD. "And, with type 1 diabetes in the U.S. and many countries around the world at about a 3% annual rate, every lead is significant. The research gives impetus to better understanding how the bacterial flora in our body influences host immune defenses and responses that provide resistance to the development of type 1 diabetes. This understanding may provide new therapeutic approaches to prevention."

For the study, teams led by Li Wen at Yale and Alexander V. Chervonsky at the University of Chicago used mice that under normal conditions, would not develop diabetes. If raised in a germ-free environment, however, the mice developed diabetes. But mice that were exposed to common intestinal bacteria maintained a lower risk for the disease.


'/>"/>

Contact: Michael Cook
mcook@jdrf.org
212-479-7510
Juvenile Diabetes Research Foundation International
Source:Eurekalert

Related biology news :

1. Mandate for public access to NIH-funded research poised to become law
2. Irritating smells alert special cells, NIH-funded study finds
3. OSU technologies funded for development
4. JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control
5. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
6. A study by the MUHC and McGill University opens a new door to understanding cancer
7. Study begins to reveal clues to the cause and progression of sepsis
8. Clones on task serve greater good, evolutionary study shows
9. New study warns limited carbon market puts 20 percent of tropical forest at risk
10. New study examines how rearing environment can alter navigation
11. Study links cat disease to flame retardants in furniture and to pet food
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Controller General of Immigration from Maldives Mr. Mohamed Anwar and ... international IAIR Award for the most innovative high security ePassport and eGates  ... ... Maldives Immigration Controller General, Mr. Mohamed Anwar ... right) have received the IAIR award for the "Most innovative high security ...
(Date:3/22/2017)... , March 21, 2017   Neurotechnology ... object recognition technologies, today announced the release of ... (SDK), which provides improved facial recognition using up ... on a single computer. The new version uses ... improve accuracy, and it utilizes a Graphing Processing ...
(Date:3/20/2017)... March 20, 2017 PMD Healthcare announces the ... and Wellness Management System (WMS), a remote, real-time lung ... 2010, PMD Healthcare is a Medical Device, Digital Health, ... dedicated to creating innovative solutions that empower people to ... intent focus, PMD developed the first ever personal spirometer, ...
Breaking Biology News(10 mins):
(Date:4/26/2017)... ... 2017 , ... NextSteps 2017, NetDimensions’ annual global user conference, ... May on the following dates: , ?    London, UK from May 10-11, ?    New Orleans, ... Performance Institute will be the opening keynote speaker at the NextSteps EMEA ...
(Date:4/26/2017)... HATFIELD, Pa. , April 26, 2017 /PRNewswire/ ... drug delivery platform, has signed a collaborative and ... through Dr. Silvia Muro . The overall ... pharmacokinetics and pharmacodynamics of various 3DNA designs and ... aims involve targeting diseases of the vasculature as ...
(Date:4/25/2017)... California (PRWEB) , ... April 25, 2017 , ... ... Intelligence (AI), leading supplier of Common Lisp (CL) development tools, and market leader ... , which includes key performance enhancements now available within the most effective system ...
(Date:4/25/2017)... , April 25, 2017 ... has licensed its novel immune-modulating technology to an undisclosed ... and allergy. Tregitopes, pronounced T·rej·itopes, are ... immunoglobulin by EpiVax CEO Annie De Groot ... intravenous immunoglobulin G, an autoimmune disease therapy, Tregitopes ...
Breaking Biology Technology: